Motus GI back on NASDAQ

Medical endoscopy solutions company Motus GI received formal notice that it can once again trade on the NASDAQ stock market after falling below the minimum bid price requirement earlier this year, according to an Aug. 11 news release.

Advertisement

Motus GI joined the stock market in early 2018 and fell below the minimum bid price requirement in early 2022, according to a Feb. 24 news release. 

On Aug. 9, the company was able to list and trade stock on the market again after its ordinary shares reached a closing bid price at or greater than $1 per share for 10 consecutive business days.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • OSF HealthCare Saint Anthony Medical Center in Rockford, Ill., has added Tarik Firozi, MD, according to an April 6 report…

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

Advertisement

Comments are closed.